English | Español
Patient Daily | Nov 20, 2025

UTHealth Houston researcher leads trial showing benefits of new oral GLP-1 pill for diabetes
Patient Daily | Nov 20, 2025

Baylor College receives over $15 million from CPRIT for cancer research projects
Patient Daily | Nov 19, 2025

Sen. Cassidy: 340B ‘program's dramatic growth led to higher costs for patients and for taxpayers'
Patient Daily | Nov 19, 2025

Patients Rising CEO on 340B reform: ‘Patients aren’t seeing the discounts — everyone is just paying more downstream’
Patient Daily | Nov 19, 2025

American Lung Association highlights free lung health navigator program for World COPD Day
Patient Daily | Nov 19, 2025

Precautions advised by allergists for managing holiday allergy and asthma triggers
Patient Daily | Nov 19, 2025

Dauten family donates $25 million for new Northwestern Medicine Behavioral Health Institute
Patient Daily | Nov 18, 2025

Pacific Research Institute CEO: 340B misuse is 'reducing competition, narrowing patient choices, and driving costs up'

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'